Your browser version may not work well with NCBI's Web applications. More information
here...
-
Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis.
Clinical Psychopharmacology Unit, Sub-Department of Clinical Health Psychology, University College London, London, UK. c.morgan@ucl.ac.uk
Cannabis contains various cannabinoids, two of which have almost opposing actions: Delta9-tetrahydrocannabinol (Delta9-THC) is psychotomimetic, whereas cannabidiol (CBD) has antipsychotic effects. Hair samples were analysed to examine levels of Delta9-THC and CBD in 140 individuals. Three clear groups emerged: ;THC only', ;THC+CBD' and those with no cannabinoid in hair. The THC only group showed higher levels of positive schizophrenia-like symptoms compared with the no cannabinoid and THC+CBD groups, and higher levels of delusions compared with the no cannabinoid group. This provides evidence of the divergent properties of cannabinoids and has important implications for research into the link between cannabis use and psychosis.
PMID: 18378995 [PubMed - in process]
-
Related Articles
-
Patient Drug Information
-
Dronabinol (Marinol®)
Dronabinol is used to treat nausea and vomiting caused by chemotherapy in people who have already taken other medications to treat this type of nausea and vomiting without good results. Dronabinol is also used to treat l...